(Q27851394)

English

Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib (English)
0 references
0 references
0 references
0 references
David M Jackman
0 references
Beow Y Yeap
0 references
Neal Lindeman
0 references
Alison J Holmes
0 references
Victoria A Joshi
0 references
Daphne W Bell
0 references
Mark S Huberman
0 references
Balazs Halmos
0 references
Michael S Rabin
0 references
Thomas J Lynch
0 references
Bruce E Johnson
0 references
1 July 2006
0 references
12
0 references
13
0 references
3908-14
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit